Vaccinating Sri Lanka Against COVID-19

The study assesses the fiscal implications of reaching a target of vaccinating 80 per cent of Sri Lanka’s population against COVID-19. Arrangements are being made to secure vaccinations for 20 per cent of the country’s population through the WHOs COVAX procurement facility. The cost-benefit analysis of vaccinating the remaining ‘non-priority’ groups (accounting for 60 per cent of the population) to reach the 80 per cent coverage target will be approximated, and the associated fiscal trade-offs of using government budget for this purpose will be assessed.

 

Research team

Kithmina Hewage
View profile
Harini Weerasekara
View profile

Funding

IPS